Skip to main content

Table 4 Urogenital and anal organ agents prescribed to the patients

From: Characteristics of CYP3A4-related potential drug-drug interactions in outpatients receiving prescriptions from multiple clinical departments

Objective drug

Number of cases

CYP3A4 competitive or inhibitory action

Mirabegron

46

YES

Naftopidil

23

YES

Tamsulosin hydrochloride

18

YES

Vibegron

16

YES

Silodosin

9

YES

Imidafenacin

8

YES

Fesoterodine fumarate

7

YES

Melilot extract

4

NO

Solifenacin succinate

3

YES

Cernitin pollen extract

1

NO